JPWO2022103221A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022103221A5 JPWO2022103221A5 JP2023525999A JP2023525999A JPWO2022103221A5 JP WO2022103221 A5 JPWO2022103221 A5 JP WO2022103221A5 JP 2023525999 A JP2023525999 A JP 2023525999A JP 2023525999 A JP2023525999 A JP 2023525999A JP WO2022103221 A5 JPWO2022103221 A5 JP WO2022103221A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amino acid
- renal
- fusion protein
- reduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20200152247 | 2020-11-13 | ||
| KR10-2020-0152247 | 2020-11-13 | ||
| PCT/KR2021/016630 WO2022103221A1 (ko) | 2020-11-13 | 2021-11-15 | 치료학적 효소 융합단백질의 파브리병에 기인하거나 동반되는 신장질환 예방 및 치료 용도 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023549323A JP2023549323A (ja) | 2023-11-24 |
| JPWO2022103221A5 true JPWO2022103221A5 (https=) | 2024-11-25 |
| JP2023549323A5 JP2023549323A5 (https=) | 2024-11-25 |
Family
ID=81602509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525999A Pending JP2023549323A (ja) | 2020-11-13 | 2021-11-15 | 治療学的酵素融合タンパク質のファブリー病に起因する又は伴う腎臓疾患の予防及び治療用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230405093A1 (https=) |
| EP (1) | EP4245311A4 (https=) |
| JP (1) | JP2023549323A (https=) |
| KR (1) | KR20220065719A (https=) |
| CN (1) | CN116419760A (https=) |
| AU (1) | AU2021378707A1 (https=) |
| CA (1) | CA3196258A1 (https=) |
| CO (1) | CO2023006437A2 (https=) |
| IL (1) | IL302858A (https=) |
| MX (1) | MX2023005580A (https=) |
| WO (1) | WO2022103221A1 (https=) |
| ZA (1) | ZA202304534B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202525329A (zh) * | 2023-09-14 | 2025-07-01 | 南韓商綠十字股份有限公司 | 含有α－半乳糖苷酶Ａ融合蛋白的新穎冷凍乾燥製劑 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| HUE047173T2 (hu) * | 2010-03-01 | 2020-04-28 | Bayer Healthcare Llc | Optimalizált monoklonális ellenanyagok szöveti faktor útvonal inhibitor (TFPI) ellen |
| WO2015009052A1 (ko) * | 2013-07-16 | 2015-01-22 | 일동제약 주식회사 | 하이브리드 면역글로불린 fc와 효소의 융합단백질 |
| AR107483A1 (es) * | 2016-01-29 | 2018-05-02 | Hanmi Pharm Ind Co Ltd | Conjugado de enzimas terapéuticas |
| EP3565583A4 (en) * | 2017-01-05 | 2020-12-02 | Protalix Ltd. | TREATMENT DIET FOR THE TREATMENT OF FABRY'S DISEASE USING STABILIZED ALPHA-GALACTOSIDASE |
| SG11202000115SA (en) * | 2017-07-07 | 2020-02-27 | Hanmi Pharmaceutical Co Ltd | Novel therapeutic enzyme fusion protein and use thereof |
| FR3069340A1 (fr) * | 2017-07-21 | 2019-01-25 | Arkema France | Procede de controle de l'orientation des nano-domaines d'un copolymere a blocs |
| MX2020006635A (es) * | 2017-12-22 | 2020-12-10 | Hanmi Pharm Ind Co Ltd | Proteína de fusión enzimática terapéutica que tiene una nueva estructura y uso de la misma. |
-
2021
- 2021-11-15 JP JP2023525999A patent/JP2023549323A/ja active Pending
- 2021-11-15 US US18/036,580 patent/US20230405093A1/en active Pending
- 2021-11-15 IL IL302858A patent/IL302858A/en unknown
- 2021-11-15 KR KR1020210156861A patent/KR20220065719A/ko active Pending
- 2021-11-15 MX MX2023005580A patent/MX2023005580A/es unknown
- 2021-11-15 CA CA3196258A patent/CA3196258A1/en active Pending
- 2021-11-15 AU AU2021378707A patent/AU2021378707A1/en active Pending
- 2021-11-15 WO PCT/KR2021/016630 patent/WO2022103221A1/ko not_active Ceased
- 2021-11-15 EP EP21892388.6A patent/EP4245311A4/en active Pending
- 2021-11-15 CN CN202180075093.2A patent/CN116419760A/zh active Pending
-
2023
- 2023-04-19 ZA ZA2023/04534A patent/ZA202304534B/en unknown
- 2023-05-16 CO CONC2023/0006437A patent/CO2023006437A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3528833B1 (en) | Methods for treating muscle wasting and bone disease using novel hybrid actriib ligand trap proteins | |
| ES2280083T3 (es) | Composiciones de proteinas de fusion ob y metodos. | |
| CN101553243B (zh) | 组织损伤修复中的基质细胞衍生因子1的蛋白酶抗性突变体 | |
| US20230348565A1 (en) | Methods of using activin receptor type ii variants | |
| JP2018070625A5 (https=) | ||
| JP2006516886A5 (https=) | ||
| JP2025144567A (ja) | グルカゴン、及びｇｌｐ－１受容体及びｇｉｐ受容体二重アゴニストを含む組成物及びその治療学的使用 | |
| RU2005115477A (ru) | Нейтрализующие антитела против gdf-8 и их применение | |
| KR20160003848A (ko) | 치료용 펩티드 | |
| JP2020526497A5 (https=) | ||
| RU2007119989A (ru) | Композиции, слитые конструкции и конъюгаты plad домена | |
| JP2023510864A (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体の持続型結合体の肺疾患の治療的使用 | |
| JPH08504210A (ja) | 結合生物活性ペプチドを使用した敗血症性ショックの治療 | |
| JPWO2022103221A5 (https=) | ||
| CA3251039A1 (en) | NEW CD200 FUSION PROTEINS | |
| WO2023164898A1 (zh) | 一种重组融合蛋白的制剂 | |
| IL310164A (en) | Multi-chain chimeric polypeptides and use thereof in the treatment of liver diseases | |
| WO2025147483A1 (en) | Methods of using activin receptor type ii chimeras | |
| JP2023524866A (ja) | 抗ｉｌ－３３抗体の処方物 | |
| WO2024125445A1 (zh) | 一种靶向TNF-α与IL-17A的双特异性融合蛋白及其用途 | |
| CN113365651A (zh) | 包含胰岛素和胰高血糖素的药物组合物 | |
| JP5004408B2 (ja) | 抗ｈｉｖ組成物、その製造方法及び医薬 | |
| JPWO2023110983A5 (https=) | ||
| KR20220140443A (ko) | 글루카곤 유도체를 포함하는 만성 신장 질환 예방 또는 치료용 약학 조성물 | |
| CN101341170B (zh) | 抗白介素-22结合蛋白的抗体及其用途 |